Lineage Cell Therapeutics, Inc.
USD1.33
-0.02 (-1.48%)
CEO
Brian Culley
IPO Date
1992-03-05
Sector
Healthcare
Industry
Biotechnology
Exchange
AMEX
Country
US
Open
$1.33
Prev. Close
$1.35
Day Low
$1.32
Day High
$1.37
52W Low
$0.85
52W High
$2.09
Market Cap
$0.33B
Volume
0.30M
| -5.4 |
| 31 Dec 2023 | FY | 92.5% | -240.2% | -33.9% | -21.3% | 0.05 | 2.14 | -8.8 |
| 31 Dec 2022 | FY | 95.0% | -178.7% | -35.8% | -21.2% | 0.05 | 3.16 | -7.6 |
| 31 Dec 2021 | FY | 63.4% | -1104.2% | -46.6% | -24.6% | 0.03 | 2.37 | -9.4 |
| 31 Dec 2020 | FY | 50.2% | -2671.3% | -21.5% | -19.1% | 0.04 | 5.66 | -12.8 |
| 31 Dec 2019 | FY | 72.1% | -792.2% | -10.4% | -9.3% | 0.05 | 8.86 | -11.1 |
| 31 Dec 2018 | FY | 78.7% | -3247.9% | -49.0% | -45.2% | 0.02 | 5.34 | -2.5 |
| 31 Dec 2017 | FY | 90.6% | -1114.7% | -12.3% | -11.5% | 0.01 | 6.20 | -12.3 |
| 31 Dec 2016 | FY | 84.1% | 1490.8% | 28.5% | 23.5% | 0.03 | 2.90 | 10.5 |
| 112.9 |
| 30 Sept 2025 | Q3 | 99.9% | -809.0% | -135.1% | -33.2% | 0.12 | 4.50 | -3.2 |
| 30 Jun 2025 | Q2 | 98.6% | -1101.8% | -63.0% | -33.6% | 0.04 | 4.08 | -1.7 |
| 31 Mar 2025 | Q1 | 97.6% | -275.6% | -5.2% | -3.7% | 0.03 | 3.82 | -6.2 |
| 31 Dec 2024 | Q4 | 94.6% | -114.1% | -4.2% | -2.9% | 0.03 | 3.65 | -7.7 |
| 30 Sept 2024 | Q3 | 99.0% | -80.3% | -4.6% | -3.1% | 0.04 | 2.48 | -14.1 |
| 30 Jun 2024 | Q2 | 96.9% | -409.1% | -8.4% | -5.6% | 0.04 | 2.64 | -7.8 |
| 31 Mar 2024 | Q1 | 81.1% | -453.0% | -9.0% | -6.0% | 0.04 | 2.71 | -10.2 |
| 31 Dec 2023 | Q4 | 79.4% | -228.7% | -7.5% | -4.7% | 0.05 | 2.14 | -9.9 |